Published in Medical Device Law Weekly, February 3rd, 2008
"All composites showed reduced cell numbers compared to glass controls. Fresh specimens of Signum+EM exhibited the least cytotoxicity, followed by Gradia Enamel E3 and Sinfony E3 and then SR Adoro, S1. For specimens with 7-day incubation, 3 of the composites...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly